Literature DB >> 31599684

Attitudes Toward Hypothetical Uses of Gene-Editing Technologies in Parents of People with Autosomal Aneuploidies.

Erika Snure Beckman1, Natalie Deuitch1, Marsha Michie2, Megan A Allyse3, Kirsten A Riggan3, Kelly E Ormond1,4.   

Abstract

Researchers are exploring the use of gene-editing technologies to prevent and/or treat genetic conditions in humans. Stakeholder views, including those of patient and family populations, are important in the ongoing bioethical discussion. We conducted 27 semi-structured interviews with parents of people with trisomy 21 (T21; N = 10), trisomy 18 (T18; N = 8), and trisomy 13 (T13; N = 9)-conditions not previously studied in regard to attitudes toward hypothetical gene editing. While many discussions focus on the morality of gene editing, parents in our study focused on quality of life and concerns about changing their children's identity. All participants prioritized ameliorating life-threatening health issues when those were present; many also emphasized increasing their children's communication and cognitive ability. These results suggest that patient populations with the lived experience of genetic conditions have unique concerns that may differ from broader discourse.

Entities:  

Mesh:

Year:  2019        PMID: 31599684     DOI: 10.1089/crispr.2019.0021

Source DB:  PubMed          Journal:  CRISPR J        ISSN: 2573-1599


  3 in total

1.  The View from the Benches: Scientists' Perspectives on the Uses and Governance of Human Gene-Editing Research.

Authors:  Margaret Waltz; Eric T Juengst; Teresa Edwards; Gail E Henderson; Kristine J Kuczynski; John M Conley; Paige Della-Penna; R Jean Cadigan
Journal:  CRISPR J       Date:  2021-08

2.  Toward Anticipatory Governance of Human Genome Editing: A Critical Review of Scholarly Governance Discourse.

Authors:  John P Nelson; Cynthia L Selin; Christopher T Scott
Journal:  J Responsible Innov       Date:  2021-07-29

3.  Phenotypic features in MECP2 duplication syndrome: Effects of age.

Authors:  Sarika U Peters; Cary Fu; Eric D Marsh; Tim A Benke; Bernard Suter; Steve A Skinner; David N Lieberman; Shannon Standridge; Mary Jones; Arthur Beisang; Timothy Feyma; Peter Heydeman; Robin Ryther; Daniel G Glaze; Alan K Percy; Jeffrey L Neul
Journal:  Am J Med Genet A       Date:  2020-11-10       Impact factor: 2.802

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.